Ferrer and Prilenia begin confirmatory study of pridopidine in Huntington’s disease

3 hours ago

Add Comment

by David Miller

945 Views

New phase 3 trial to assess impact on disease progression, function and quality of life

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

You may also like

About the author

David Miller

Leave a Comment X